Yoichiro Tohi

43PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersAutonomic nervous systemPharmacogenomicsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jun 17, 2026
Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database.

|Apr 13, 2026
Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic Therapy.

Naoki Akagi, Akihiko Nagoshi, Masashi Kubota

|Mar 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel.

Takuma Kato, Yoichiro Tohi, Atsushi Takamoto

|Jan 31, 2026
Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis.

Yohei Abe, Rikiya Taoka, Asuka Kaji

|Jan 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Dec 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium.

Hideo Fukuhara, Shingo Nishimura, Keita Kobayashi

Pageof 8

Frequent Collaborators

15 joint publications

Mikio Sugimoto

10 joint publications

Takuma Kato

5 joint publications

Rikiya Taoka

5 joint publications

Satoshi Katayama